Reperfusion therapy for ST elevation acute myocardial infarction 2010/2011: current status in 37 ESC countries
Top Cited Papers
Open Access
- 12 January 2014
- journal article
- research article
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 35 (29), 1957-1970
- https://doi.org/10.1093/eurheartj/eht529
Abstract
Primary percutaneous coronary intervention (PPCI) is the preferred reperfusion therapy in ST-elevation myocardial infarction (STEMI). We conducted this study to evaluate the contemporary status on the use and type of reperfusion therapy in patients admitted with STEMI in the European Society of Cardiology (ESC) member countries. A cross-sectional descriptive study based on aggregated country-level data on the use of reperfusion therapy in patients admitted with STEMI during 2010 or 2011. Thirty-seven ESC countries were able to provide data from existing national or regional registries. In countries where no such registries exist, data were based on best expert estimates. Data were collected on the use of STEMI reperfusion treatment and mortality, the numbers of cardiologists, and the availability of PPCI facilities in each country. Our survey provides a brief data summary of the degree of variation in reperfusion therapy across Europe. The number of PPCI procedures varied between countries, ranging from 23 to 884 per million inhabitants. Primary percutaneous coronary intervention and thrombolysis were the dominant reperfusion strategy in 33 and 4 countries, respectively. The mean population served by a single PPCI centre with a 24-h service 7 days a week ranged from 31 300 inhabitants per centre to 6 533 000 inhabitants per centre. Twenty-seven of the total 37 countries participated in a former survey from 2007, and major increases in PPCI utilization were observed in 13 of these countries. Large variations in reperfusion treatment are still present across Europe. Countries in Eastern and Southern Europe reported that a substantial number of STEMI patients are not receiving any reperfusion therapy. Implementation of the best reperfusion therapy as recommended in the guidelines should be encouraged.Keywords
This publication has 39 references indexed in Scilit:
- Regional system of care for ST-segment elevation myocardial infarction in the Northern Alps: A controlled pre- and postintervention studyArchives of Cardiovascular Diseases, 2012
- ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevationEuropean Heart Journal, 2012
- Developing primary PCI as a national reperfusion strategy for patients with ST-elevation myocardial infarction: the UK experienceEuroIntervention, 2012
- Implementation of primary angioplasty in Europe: Stent for Life initiative progress reportEuroIntervention, 2012
- 25 year trends in first time hospitalisation for acute myocardial infarction, subsequent short and long term mortality, and the prognostic impact of sex and comorbidity: a Danish nationwide cohort studyBMJ, 2012
- Barriers to Implementation of Primary Percutaneous Coronary Intervention in EuropeEuropean Cardiology Review, 2011
- Network models for large cities: the European experienceHeart, 2010
- Reperfusion therapy for ST elevation acute myocardial infarction in Europe: description of the current situation in 30 countriesEuropean Heart Journal, 2009
- The expanded Global Registry of Acute Coronary Events: Baseline characteristics, management practices, and hospital outcomes of patients with acute coronary syndromesAmerican Heart Journal, 2009
- Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trialsThe Lancet, 2003